| __timestamp | ADMA Biologics, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 1213000 |
| Thursday, January 1, 2015 | 6745968 | 3425000 |
| Friday, January 1, 2016 | 8494742 | 6311000 |
| Sunday, January 1, 2017 | 18092835 | 9518000 |
| Monday, January 1, 2018 | 22502922 | 28080000 |
| Tuesday, January 1, 2019 | 25910757 | 36550000 |
| Wednesday, January 1, 2020 | 35050817 | 46125000 |
| Friday, January 1, 2021 | 42896889 | 68486000 |
| Saturday, January 1, 2022 | 52458024 | 92032000 |
| Sunday, January 1, 2023 | 59020000 | 117532000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, effective cost management is crucial for sustaining growth and innovation. Over the past decade, ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, ADMA Biologics saw a steady increase in SG&A expenses, growing by approximately 1,100%. This reflects their strategic investments in expanding operations and market reach. In contrast, Rhythm Pharmaceuticals experienced a staggering 9,600% rise in the same period, highlighting their aggressive expansion and development strategies.
By 2023, Rhythm Pharmaceuticals' SG&A expenses were nearly double those of ADMA Biologics, indicating a more rapid scale-up. These insights underscore the importance of balancing cost management with growth ambitions in the biotech sector, where financial agility can be a key differentiator.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared